Skip to Content

New Additions to Drugs.com for 2021

We update the Drugs.com database on a regular cycle. The following new drug information was added in 2021:

Kloxxado
May 2, 2021 - Kloxxado (naloxone hydrochloride) nasal spray is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.

Zynlonta
Apr 27, 2021 - Zynlonta (loncastuximab tesirine-lpyl) is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

Jemperli
Apr 27, 2021 - Jemperli (dostarlimab-gxly) is a programmed death receptor-1 (PD-1)–blocking antibody for the treatment of women with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer.

Nextstellis
Apr 21, 2021 - Nextstellis (drospirenone and estetrol) is a progestin and estrogen combination indicated for use by females of reproductive potential to prevent pregnancy.

Mydayis
Apr 9, 2021 - Mydayis (amphetamine mixed salts) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.

Qelbree
Apr 6, 2021 - Qelbree (viloxazine hydrochloride) is a serotonin norepinephrine modulating agent (SNMA) for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age.

Roszet
Apr 1, 2021 - Roszet (ezetimibe and rosuvastatin) is a combination of the approved intestinal cholesterol inhibitor ezetimibe (Zetia) and the HMG Co-A reductase inhibitor rosuvastatin (Crestor) indicated for use in adults to reduce low-density lipoprotein cholesterol (LDL-C) in patients with primary non-familial hyperlipidemia and patients with homozygous familial hypercholesterolemia (HoFH).

Abecma
Mar 28, 2021 - Abecma (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous chimeric antigen receptor (CAR) T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma.

Zegalogue
Mar 25, 2021 - Zegalogue (dasiglucagon) is a glucagon analog antihypoglycemic agent for the treatment of severe hypoglycemia in diabetes patients aged 6 years and older.

Ponvory
Mar 21, 2021 - Ponvory (ponesimod) is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator for the treatment of adult patients with relapsing multiple sclerosis (MS).

Fotivda
Mar 14, 2021 - Fotivda (tivozanib) is a tyrosine kinase inhibitor for the treatment of advanced renal cell carcinoma.

Pepaxto
Mar 10, 2021 - Pepaxto (melphalan flufenamide) is an anticancer peptide-drug conjugate indicated for use in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Azstarys
Mar 3, 2021 - Azstarys (dexmethylphenidate and serdexmethylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.

Evkeeza
Feb 13, 2021 - Evkeeza (evinacumab-dgnb) is an angiopoietin-like 3 (ANGPTL3) inhibitor indicated for the treatment of patients with homozygous familial hypercholesterolemia (HoFH).

Breyanzi
Feb 9, 2021 - Breyanzi (lisocabtagene maraleucel) is a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

Ukoniq
Feb 8, 2021 - Ukoniq (umbralisib) is an oral, once-daily, dual inhibitor of PI3K-delta and CK1-epsilon for the treatment for patients with previously treated marginal zone lymphoma (MZL) and follicular Lymphoma (FL).

Tepmetko
Feb 3, 2021 - epmetko (tepotinib) is an oral MET inhibitor for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations.

Vocabria
Jan 27, 2021 - Vocabria (cabotegravir) is a prescription medicine used in combination with Edurant (rilpivirine) as part of the Cabenuva (cabotegravir, rilpivirine) injectable treatment regimen for adults with HIV-1 infection.

Lupkynis
Jan 26, 2021 - Lupkynis (voclosporin) is a calcineurin-inhibitor immunosuppressant indicated for the treatment of adults with active lupus nephritis (LN).

Cabenuva
Jan 23, 2021 - Cabenuva (cabotegravir and rilpivirine) is a long-acting, injectable regimen of the HIV-1 integrase strand transfer inhibitor (INSTI) cabotegravir, and the HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine indicated as a complete regimen for the treatment of HIV-1 infection in adults.

Verquvo
Jan 21, 2021 - VERQUVO is a prescription medicine used to treat adults who have chronic heart failure with reduced ejection fraction (HFrEF).

Gemtesa
Jan 1, 2021 - Gemtesa (vibegron) is a prescription medicine used to treat urge urinary incontinence, urinary urgency, and urinary frequency due to overactive bladder.

Browse additions by year: